Changing Therapeutic Paradigms For Intestinal Health: Diet As A Therapeutic Strategy In Gastroenterology.
Funder
National Health and Medical Research Council
Funding Amount
$640,210.00
Summary
Irritable bowel syndrome (IBS) affects 1 in 7 adults in Australia. IBS symptoms include abdominal pain, bloating and wind. My team has shown that fermentable short chain carbohydrates (FODMAPs) present in many foods are responsible for triggering these symptoms. The Low FODMAP diet is now being adopted worldwide as first-line management therapy for IBS. The delivery of this research worldwide has been possible through the use of a smartphone app: The Monash Uni Low FODMAP diet.